Touch-down reverse transcriptase-PCR detection of IgV(H) rearrangement and Sybr-Green-based real-time RT-PCR quantitation of minimal residual disease in patients with chronic lymphocytic leukemia
- PMID: 16035732
- DOI: 10.2165/00066982-200509010-00004
Touch-down reverse transcriptase-PCR detection of IgV(H) rearrangement and Sybr-Green-based real-time RT-PCR quantitation of minimal residual disease in patients with chronic lymphocytic leukemia
Abstract
Background: Patients with chronic lymphocytic leukemia (CLL) can relapse even after aggressive therapy and autografts. It is commonly assumed that to prevent relapse the level of minimal residual disease (MRD) should be as low as possible. To evaluate MRD, highly sensitive quantitative assays are needed.
Aim: The aim of the study was to develop a robust and sensitive method for detection of the clonal immunoglobulin heavy-chain variable (IgV(H)) rearrangement in CLL and to introduce a highly sensitive and specific methodology for MRD monitoring in patients with CLL who undergo intensive treatment.
Methods: As a prerequisite for MRD detection, touch-down reverse transcriptase (RT)-PCR using degenerate primers were used for the diagnostic identification of (H) gene rearrangement(s). For quantitative MRD detection in 18 patients, we employed a real-time RT-PCR assay (RQ-PCR) making use of patient-specific primers and the cost-saving Sybr-Green reporter dye (SG). For precise calibration of RQ-PCR, patient-specific IgV(H) sequences were cloned.
Results: Touch-down RT-PCR with degenerate primers allowed the successful detection of IgV(H) clonal rearrangement(s) in 252 of 257 (98.1%) diagnostic samples. Biallelic rearrangements were found in 27 of 252 (10.7%) cases. Degenerate primers used for the identification of clonal expansion at diagnosis were not sensitive enough for MRD detection. In contrast, our RQ-PCR assay using patient-specific primers and SG reached the sensitivity of 10(-)(6). We demonstrated MRD in each patient tested, including four of four patients in complete remission following autologous hematopoietic stem cell transplantation (HSCT) and three of three following allogeneic 'mini'-HSCT. Increments in MRD might herald relapse; aggressive chemotherapy could induce molecular remission.
Conclusions: Our touch-down RT-PCR has higher efficiency to detect clonal IgV(H) rearrangements including the biallelic ones. MRD quantitation of IgV(H) expression using SG-based RQ-PCR represents a highly specific, sensitive, and economic alternative to the current quantitative methods.
Similar articles
-
Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.Leukemia. 2004 Oct;18(10):1637-45. doi: 10.1038/sj.leu.2403478. Leukemia. 2004. PMID: 15343348
-
Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye.Exp Hematol. 2002 Oct;30(10):1170-7. doi: 10.1016/s0301-472x(02)00892-5. Exp Hematol. 2002. PMID: 12384148
-
MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.Methods Mol Biol. 2019;1956:199-228. doi: 10.1007/978-1-4939-9151-8_9. Methods Mol Biol. 2019. PMID: 30779036
-
Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement.Hematol Cell Ther. 1997 Jun;39(3):119-24. doi: 10.1007/s00282-997-0119-z. Hematol Cell Ther. 1997. PMID: 9262987 Review.
-
Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.Leukemia. 2003 Jun;17(6):1013-34. doi: 10.1038/sj.leu.2402922. Leukemia. 2003. PMID: 12764363 Review.
Cited by
-
Identification of leukemia-specific fusion gene transcripts with a novel oligonucleotide array.Mol Diagn Ther. 2007;11(1):21-8. doi: 10.1007/BF03256220. Mol Diagn Ther. 2007. PMID: 17286448
-
Assessing minimal residual disease in chronic lymphocytic leukemia.Curr Hematol Malig Rep. 2008 Jan;3(1):47-53. doi: 10.1007/s11899-008-0008-8. Curr Hematol Malig Rep. 2008. PMID: 20425446 Review.
-
Quantitation of minimal residual disease in patients with chronic lymphocytic leukemia using locked nucleic acid-modified, fluorescently labeled hybridization probes and real-time PCR technology.Mol Diagn Ther. 2007;11(5):325-35. doi: 10.1007/BF03256253. Mol Diagn Ther. 2007. PMID: 17963420
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials